Effect of maternal body mass index on in vitro response to tocolytics in term myometrium

  • Giuseppe Chiossi
  • , Maged M. Costantine
  • , Ancizar Betancourt
  • , Gary D.V. Hankins
  • , Monica Longo
  • , George R. Saade
  • , Egle Bytautiene

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Objective: We sought to investigate the effect of body mass index (BMI) on in vitro response to tocolytics. Study Design: Myometrial biopsies were obtained at the time of scheduled cesarean deliveries from term nonlaboring women with BMI ≤29.9 (26.3 ± 1.3; n = 7), 30-34.9 (31.8 ± 1.2; n = 16), and ≥35 (39.5 ± 4.9; n = 9). Tissue strips were suspended in organ chambers for isometric tension recording. The effects of cumulative doses (10-10 to 10-5 mol/L) of nifedipine or indomethacin on spontaneous uterine contractility were determined. Areas under the contraction curve were compared using 1-way analysis of variance with Tukey post hoc test. Results: Myometrial response to tocolytics did not differ between the BMI groups. Nifedipine, but not indomethacin, significantly inhibited myometrial contractility independent of BMI. Conclusion: BMI does not affect uterine response to tocolytics in isolated uterine tissue from term nonlaboring women.

Original languageEnglish (US)
Pages (from-to)261.e1-261.e5
JournalAmerican journal of obstetrics and gynecology
Volume203
Issue number3
DOIs
StatePublished - Sep 2010
Externally publishedYes

Keywords

  • indomethacin
  • nifedipine
  • obesity
  • organ chamber
  • oxytocin
  • uterine contractility

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Effect of maternal body mass index on in vitro response to tocolytics in term myometrium'. Together they form a unique fingerprint.

Cite this